Technical Analysis for GTHX - G1 Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 19.585 -0.78% -0.16
GTHX closed up 1.44 percent on Tuesday, January 15, 2019, on 29 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Flat
See historical GTHX trend table...

Date Alert Name Type % Chg
Jan 15 Narrow Range Bar Range Contraction -0.79%
Jan 15 Wide Bands Range Expansion -0.79%
Jan 14 Narrow Range Bar Range Contraction 0.64%
Jan 14 NR7 Range Contraction 0.64%
Jan 14 Stochastic Reached Overbought Strength 0.64%
Jan 14 Multiple of Ten Bearish Other 0.64%
Jan 14 Weak + Overbought Other 0.64%
Jan 14 Wide Bands Range Expansion 0.64%
Jan 14 Weak, Overbought and Reversal Signs Reversal 0.64%
Jan 14 Overbought Stochastic Strength 0.64%

Older signals for GTHX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
G1 Therapeutics, Inc. is a United States-based clinical-stage biopharmaceutical company. The Company is engaged in developing small-molecule therapies for the treatment of cancer. Its two clinical-stage candidates are trilaciclib (G1T28) and G1T38, which are potent, selective inhibitors of the validated kinase targets CDK4/6. Trilaciclib and G1T38 are designed to be combined and enhance the anti-tumor activity of current therapies. It is also developing G1T48, an oral selective estrogen receptor degrader (SERD) for the treatment of breast cancer. The Company is evaluating trilaciclib in three Phase II clinical trials. G1T38 is being evaluated in combination with Faslodex in a Phase I b/II a trial for patients with estrogen receptor-positive, HER2-negative breast cancer.
Is GTHX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 69.57
52 Week Low 15.21
Average Volume 450,628
200-Day Moving Average 43.6647
50-Day Moving Average 31.3128
20-Day Moving Average 20.404
10-Day Moving Average 19.597
Average True Range 2.0355
ADX 45.29
+DI 11.6129
-DI 31.7983
Chandelier Exit (Long, 3 ATRs ) 28.8235
Chandelier Exit (Short, 3 ATRs ) 21.3165
Upper Bollinger Band 27.5085
Lower Bollinger Band 13.2995
Percent B (%b) 0.45
BandWidth 69.638306
MACD Line -3.3369
MACD Signal Line -4.0767
MACD Histogram 0.7398
Fundamentals Value
Market Cap 558.35 Million
Num Shares 28.3 Million
EPS -11.02
Price-to-Earnings (P/E) Ratio -1.79
Price-to-Sales 0.00
Price-to-Book 4.87
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 21.18
Resistance 3 (R3) 21.10 20.55 20.94
Resistance 2 (R2) 20.55 20.18 20.59 20.86
Resistance 1 (R1) 20.14 19.95 20.35 20.22 20.78
Pivot Point 19.59 19.59 19.69 19.63 19.59
Support 1 (S1) 19.18 19.22 19.39 19.26 18.70
Support 2 (S2) 18.63 18.99 18.67 18.62
Support 3 (S3) 18.22 18.63 18.54
Support 4 (S4) 18.30